Tuesday, July 10, 2018

Vaccination & Population Control

Image result for fertility control images
 The “swine flu” vaccine contains ingredients that impair fertility.
Daniel Solis from the Czech Republic has researched the side-effects of the adjuvant, squalene, and discovered it is known to destroy fertility as well as causing other forms of damage.
A patent for a vaccine to impair fertility in animals contains squalene.
The plan to use this fertility-impairing adjuvant in the “swine flu” vaccine against a flu that has so far been far less irksome than the ordinary seasonal flu underscores concerns that this H1N1 mass vaccination programme mandated by WHO with the support of pharma companies such as Baxter is designed primarily to cause death and injury, and so significantly reduce the global population.
Is it any wonder that these “vaccines” are classified as bioweapons by the regulators?
For expert information on the dangers of vaccines, check out Dr Rebecca Carley’s website.
http://www.drcarley.com/
Daniel Solis has also made a formal complaint against the head of the Czech Republic’s FDA and the Deputy Health Minister for awarding a contract to Baxter worth 1,5 billion CZK without an open tender. More legal action in the Czech Republic is planned with the aim of getting Baxter’s licence to manufacture the “swine flu” vaccine at Bohumil suspended and to make Baxter accountable for the incident at the BioTest lab, which detected the live bird flu virus in vaccine material from Baxter on February 6th. Members of the lab had to be treated preventatively for bird flu and were put in quarantine.
Also, a Czech translation of “Evidence-of-the-Use-of-Pandemic-Flu-to-Depopulate-USA” can be found here: http://www.outsidermedia.cz/Obvinuji-Vas-z-masove-vrazdy-1.aspx
http://www.outsidermedia.cz/Obvinuji-Vas-z-pripravy-masove-vrazdy-II-1.aspx
“I have focused on the adjuvants made of monophosforyl lipid A (MPL) MF59TM (containing a polysorpate TweenTM 80) or AS03, AS04 also known as squalene in the proposed vaccines, which are immunosterilant or an immunocontraceptive,” Daniel Solis writes.
“The patent of the veterinary FERTILITY IMPAIRING VACCINE can be found on-line. It mentions both, the lipoid adjuvans squalene and the polysorbate TM80.
Here are the qotes from the patent and further some clinical studies about the toxicity of both.
(WO/1999/034825) FERTILITY IMPAIRING VACCINE AND METHOD OF USE
This application claims the benefit of U. S. Provisional Application No. 60/070,375, filed January 2,1998, U. S. Provisional Application No. 60/071,406, filed January 15,1998
“The vaccine of the invention preferably additionally includes an immunological adjuvant to enhance the immunological response of the subject to the glycoprotein antigen. Examples of adjuvants include Freund’s Complete Adjuvant, Freund’s Incomplete Adjuvant, and an adjuvant comprising an immunostimulant such as synthetic trehalose dicorynomycolate (STDCM) and an oil such as squalene oil (see P. Willis et al., J. Equine Vet. Sci., 14,364-370 (1994)). An adjuvant comprising synthetic trehalose dicorynemycolate, squalene oil, and a surfactant such as lecithin is preferred. Lecithin typically includes phosphatidyl choline. In a preferred embodiment the vaccine comprises oil, preferably a biodegradable oil such as squalene oil. Typically, the vaccine is prepared using an adjuvant concentrate which contains lecithin in squalene oil. The aqueous solution glycoprotein is typically a phosphate-buffered saline (PBS) solution, and additionally preferably contains Tween 80.”
Abstract:
A vaccine comprising an antigen derived from a zona pellucida glycoprotein is effective to impair fertility in animals, preferably carnivores. The vaccine can be used as an immunosterilant or an immunocontraceptive.
http://www.wipo.int/pctdb/en/wo.jsp?wo=1999034825
Description:
http://www.wipo.int/pctdb/en/wo.jsp?IA=US1998027658&wo=1999034825&DISPLAY=DESC
__________________________________________________________
Annals of Allergy, Asthma and Immunology, Volume 95, Number 6, December 2005 , pp. 593-599(7)
“Polysorbate 80 was identified as the causative agent for the anaphylactoid reaction of nonimmunologic origin in the patient. Conclusions: Polysorbate 80 is a ubiquitously used solubilizing agent that can cause severe nonimmunologic anaphylactoid reactions.”
Gajdova M, Jakubovsky J, Valky J.
Institute of Preventive and Clinical Medicine, Limbová, Bratislava.
Delayed effects of neonatal exposure to Tween 80 on female reproductive organs in rats. Food Chem Toxicol. 1993 Mar;31(3):183-90. PMID: 8473002.
“Baby female rats were injected with polysorbate 80 at days 4-7 after birth. It accelerated the maturing of the rats and caused changes to the vagina and womb lining, hormonal changes, ovary deformities and degenerative follicles.”
http://www.ncbi.nlm.nih.gov/pubmed/8473002
The Endogenous Adjuvant Squalene Can Induce a Chronic T-Cell-Mediated Arthritis in Rats
Barbro C. Carlson*, Åsa M. Jansson*, Anders Larsson, Anders Bucht and Johnny C. Lorentzen*
http://ajp.amjpathol.org/cgi/content/abstract/156/6/2057
__________________________________________________________
Now, how can WHO claim the adjuvans is harmless:
http://www.who.int/vaccine_safety/topics/adjuvants/squalene/questions_and_answers/en/index.html
when there is clear evidence of its effects provoking AI deseases:
ANTI-SQUALENE ANTIBODIES LINK GULF WAR SYNDROME TO ANTHRAX VACCINE
http://www.autoimmune.com/GWSGen.html
or
“Dr. Jules Freund creator of this oil-based adjuvant warned in 1956 that animals injected with his formulation developed terrible, incurable conditions: allergic aspermatogenesis (stoppage of sperm production), experimental allergic encephalomyelitis (the animal version of MS), allergic neuritis (inflammation of the nerves that can lead to paralysis) and other severe autoimmune disorders.
Source: : Gary Matsumoto, Vaccine A-The Covert Government Experiment That’s Killing our Soldiers and Why GI’s are Only the First Victims, Kapitola 3. “The Greatest Story Never Told” http://www.vaccine-a.com/excerpt.html”
Daniel Solis, Prague, Czech Republic
http://www.denikpolitika.cz/politici/daniel-solis/blog#31
http://www.czechfp.cz/site/?p=8009

Baillieres Clin Obstet Gynaecol. 1996 Apr;10(1):69-86.
Contraceptive vaccines.
Abstract
The basic principle of a contraceptive (or anti-fertility) vaccine is to use the body's own immune defence mechanisms to provide protection against an unplanned pregnancy. Factors such as: economic production, convenience of use, relatively long-lasting but reversible action, low failure rate, and the avoidance of mechanical devices or exogenous hormones make this approach a potentially attractive option for family planning programmes in both developing and developed countries. The major efforts in research and development have involved the prospect of active immunization against specific antigens of sperm, ovum, zygote and early embryo, and the pregnancy hormone hCG. Several anti-hCG vaccines have entered clinical trials and show promising results. These vaccines operate by preventing or interrupting pregnancy at the peri-implantation stage probably by neutralizing the luteotrophic action of hCG. The most refined vaccine is one directed against the unique C-terminal peptide on the beta-subunit of hCG. This vaccine provokes antibodies that are specific for hCG and do not cross react with hLH. Future research efforts aim to optimize the anti hCG approach, utilize new vaccine delivery systems, and broaden the spectrum of target antigens of potential utility for contraceptive vaccines.

Contraceptive vaccine for Deer Population
https://blog.humanesociety.org/2017/07/epa-gives-thumbs-vaccine-manage-deer-populations-humanely.html
Similar to the Zonastat-H vaccine, whose use in the humane control of wild horse populations is well established and effective, Zonastat-D is the trade name for the porcine zona pellucida (PZP) vaccine, adapted for deer. PZP blocks fertilization by triggering the production of antibodies that bind to the protein envelope surrounding the egg.
Adding this vaccine to the management toolbox enables wildlife managers to reduce populations gradually, often without resorting to lethal methods. Sport hunting or sharpshooting management options are often considered unsafe, impractical, and unpalatable in many urban and suburban communities.
The HSUS has traveled a long road with its partners to reach this point. Field studies on deer that provided the foundation for this registration stretch back to 1993, when scientists from the Science and Conservation Center in Billings, Montana, and the University of Toledo joined HSUS staffers to administer the first PZP-filled darts to deer at Fire Island National Seashore in New York. Subsequent HSUS field studies at the National Institute of Standards and Technology – our neighbors in Gaithersburg, Maryland – and a collaboration with Tufts University at Fripp Island, South Carolina, provided more validation. These were experimental programs, and the authorization for the use of the vaccine had only been made at these select locations.
Having treated many hundreds of deer with PZP, HSUS scientists and other researchers who have experience with the vaccine have abundant evidence to demonstrate that it’s safe for the animals, doesn’t pass through the food chain, and is effective in reducing reproductive success. When used properly, PZP reduces fawning rates by 85 to 90 percent. The EPA’s approval of the vaccine affirms those conclusions, and I’m pleased to see this piece of good news for animals coming out of the Trump administration.

Vaccines for feline contraception: GonaCon GnRH-hemocyanin conjugate immunocontraceptive.

Review article
Benka VA, et al. J Feline Med Surg. 2015.
https://www.ncbi.nlm.nih.gov/m/pubmed/26323799/

Abstract

VACCINE: GonaCon™ is the trade name of a GnRH-hemocyanin conjugate immunocontraceptive vaccine formulation shown to prevent reproduction and inhibit production of sex hormones in numerous mammalian species for extended durations. GonaCon is currently registered with the US Environmental Protection Agency (EPA) for contraception of female white-tailed deer, and GonaCon™-Equine for female wild horses and burros. Multiple formulations of this GnRH-hemocyanin conjugate immunocontraceptive vaccine have been developed at the National Wildlife Research Center in the United States.
GonaCon™—Birth Control for Deer: Questions and Answers
Q. What is GonaCon™?
A. GonaCon™ is a new gonadotropin-releasing hormone (GnRH) immunocontraceptive vaccine developed by scientists at the U.S. Department of Agriculture’s (USDA) Wildlife Services’ (WS) National Wildlife Research Center (NWRC). Presently, applications of GnRH are being researched in controlled field studies

Immunocastration of goats using anti-gonadotrophin releasing hormone vaccine.

Lents MP, et al. Theriogenology. 2018.
https://www.ncbi.nlm.nih.gov/m/pubmed/29574307/

Abstract

The aim of this study was to evaluate the immuno-sterilizing action of anti-gonadotrophin-releasing hormone (anti-GnRH) vaccine in goats.

Fertility control of “pest mammals”

Environmental degradation and economic losses due to pest populations of native and exotic mammals are widespread problems1,2 and immunocontraception has been heralded as a potential solution to these problems.345 Immunocontraceptive vaccines are designed to target the reproductive system of pest mammals by promoting antibody production against various proteins necessary for reproduction.6 The potential end result is a publicly acceptable and humane control over wildlife numbers. Nevertheless, the application of this method to wildlife populations is still in its infancy and several concerns have been raised regarding detrimental consequences of immunocontraception.7 One of the most controversial issues involves selection for individuals who fail to mount a significant contraceptive response to the immunogen and hence remain fertile in the presence of the vaccine. It is possible that the progeny of these individuals will inherit this resistance in which case alleles of genes responsible will increase in frequency. Thereby biocontrol via immunocontraception will become increasingly ineffective over time due to strong selective pressures in favour of non-response to the immunocontraceptive.8

No comments: